Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Very Young Children: A Multicenter, 3-Week, Randomized Trial.
Martin TauschmannJanet M AllenKatrin NaglMaria FritschJames YongEmily MetcalfeDominique SchaefferMuriel FichelleUlrike SchierlohAlena G ThieleDaniela AbtHarald KojzarJulia Katharina MaderSonja SlegtenhorstNicole BarberMalgorzata E WilinskaCharlotte BoughtonGianluca MusolinoJudy SibayanNathan CohenCraig KollmanSabine E HoferElke Fröhlich-ReitererThomas M KapellenCarlo L AceriniCarine de BeaufortFiona M CampbellBirgit Rami-MerharRoman Hovorkanull nullPublished in: Diabetes care (2019)
Unrestricted home use of day-and-night closed-loop in very young children with type 1 diabetes is feasible and safe. The use of diluted insulin during closed-loop does not provide additional benefits compared with standard strength insulin.